Home > Newsletters > FDAnews Device Daily Bulletin > Report Alleges Medtronic Paid Doctors to Minimize Risks of InFuse Bone Graft
FDAnews Device Daily Bulletin
Oct. 30, 2012 | Vol. 9 No. 213
Report Alleges Medtronic Paid Doctors to Minimize Risks of InFuse Bone Graft
A 16-month Senate Finance Committee investigation of Medtronic revealed dubious ties with researchers and behind-the-scenes efforts to ensure medical journals portrayed the company’s InFuse bone graft favorably, according to a report released Wednesday. Sens. Max Baucus (D-Mont.) and Chuck Grassley (R-Iowa) initiated the inquiry in June 2011, following reports that doctors investigating InFuse did not report dangerous adverse events in patients who received the device.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.